Sarcoidosis Board decisions

The VA has determined that the veteran's sarcoidosis, currently rated at 30 percent disabling, does not warrant an increase in his disability evaluation.

The Board denied the veteran's request for an effective date prior to August 30, 1996 for the grant of service connection for pulmonary sarcoidosis.

The veteran's claims for increased rating of sarcoidosis, service connection for hypertension, and PTSD are being remanded due to procedural issues and the need for additional evidence.

The veteran's polyarthralgia is not service-connected as it is not proximately due to or the result of her service-connected sarcoidosis. The Board denied her claims for TDIU and pension based on the lack of evidence showing she was unemployable or permanently disabled.

The Board has determined that the veteran's sarcoidosis, with lung and heart involvement suggestive of cor pulmonale, more closely approximates a 100 percent schedular rating under Diagnostic Code 6846.

The Board found that the appellant does not have sarcoidosis that is attributable to military service.

The veteran's claim for an increased rating for sarcoidosis is being remanded due to the need for additional VA clinical documentation and proper notification of his rights under the VCAA.

The Board has granted service connection for gastroesophageal reflux disease (GERD) and hypertension, both found to be secondary to the veteran's service-connected sarcoidosis.

The veteran's claim for a rating in excess of 10 percent for sarcoidosis with tuberculosis of the right bronchial lymph node prior to January 1, 2000 was denied. His claim for a rating in excess of 30 percent from January 1, 2000 was also denied.

The Board has determined that the veteran's current asthma condition is due to and aggravated by his service-connected sarcoidosis, resolving all reasonable doubt in favor of the veteran.

The Board has determined that the veteran's sarcoidosis is not productive of pulmonary involvement with persistent symptoms requiring chronic low dose (maintenance) or intermittent corticosteroids, and thus does not meet the criteria for a compensable evaluation.

The Board has remanded the case for additional development, including obtaining medical records and scheduling a VA examination to determine if sarcoidosis was initially manifested during service.

The VA denied the veteran's claims for increased ratings for his service-connected right eye pseudophakia, anterior uveitis from sarcoidosis and joint disease of each hand. The current evaluations are already at their maximum under the applicable diagnostic codes.

The VA denied the veteran's claim for service connection for sarcoidosis, including based on exposure to herbicides (Agent Orange). The evidence did not establish a link between the veteran's current diagnosis of sarcoidosis and his military service or any incident therein, particularly given the presumption of exposure to Agent Orange.

The veteran's appeal includes claims for service connection for various conditions, including coronary artery disease, angina pectoris, congestive heart failure, hypertension, COPD, gastroesophageal reflux, sarcoidosis cyst of the left adrenal gland, splenic cystic lesion, kidney cystic lesion, organomegaly, spinal cord tumor, spinal injury, foot drop, claw foot, hammertoes, gunshot wound residuals, and nephritis. The appeal is being remanded for additional development.

The Board has reopened the claim of service connection for sarcoid meningitis due to new and material evidence submitted by Dr. Sullivan.

The Board has determined that the veteran's prurigo nodularis or sarcoid condition does not meet the criteria for a higher rating, and thus denied her appeal to restore the prior 30 percent rating.

The Board has determined that additional development is needed to verify the veteran's claimed in-service stressors for PTSD and to determine if his current hemorrhoids are related to service. The claims will be remanded for further action.

The veteran's claim for an increased rating for sarcoidosis is being remanded due to the need for additional examination and review of medical records.

The VA denied increased ratings for pulmonary and cardiac sarcoidosis, with the veteran receiving a 30 percent evaluation for both conditions.